Latest News

digestive tract | Image credit: sdecoret -
Celltrion, Samsung Bioepis Unveil New Biosimilar Data in CD, UC at ECCO 2024

February 23rd 2024

At the Congress of European Crohn’s and Colitis Organisation (ECCO), Celltrion and Samsung Bioepis presented new finding from their respective biosimilar analyses, demonstrating positive safety and efficacy measures for the biosimilars as treatments for Crohn disease (CD) and ulcerative colitis (UC).

CFB podcast banner
Exploring the Biosimilar Horizon: Julie Reed's Predictions for 2024

February 18th 2024

Dermatologist examining skin | Image Credit: fusssergei -
Biosimilar Candidate CT-P43 Shows Biosimilarity With Ustekinumab Originator in Plaque Psoriasis

February 13th 2024

syringes | Image credit: anton -
BioRationality: Bringing the FDA and the USP Together to Revolutionize Biosimilars

February 5th 2024

FDA role | Image credit: wladimir1804 -
BioRationality: It Takes 4 to Tango—How US Entities Can Make Biosimilars Accessible

January 22nd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.